mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.5 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.22 |
0.5 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.5 |